XML 30 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 10 $ 100,498 $ (77,301) $ 23,207
Beginning balance, shares at Dec. 31, 2022 10,178        
Stock issued for director services - vested $ 0 382 382
Stock issued for director services - vested, shares 31        
Stock issued to (released from) escrow account - unvested
Stock issued to (released from) escrow account - unvested, shares (17)        
Stock-based compensation to consultants 1,704 1,704
Stock-based compensation to consultants, shares 6        
Settlement of earnout related to acquisition $ 1 7,050 7,051
Settlement of earnout related to acquisition, shares 447        
Employee stock-based compensation expense 1,950 1,950
Proceeds from issuance of common stock, pursuant to public offering $ 3 25,421 25,424
Proceeds from issuance of common stock, pursuant to public offering, shares 3,063        
Warrants exercised for cash 185 185
Warrants exercised for cash, shares 29        
Accumulated Other Comprehensive Income (AOCI) 624 624
Stock issued for acquisition and expenses 2,968 2,968
Stock issued for acquisition and expenses, shares 452        
Sale of stock under Committed Equity Facility 2,107 2,107
Sale of stock under Committed Equity Facility, shares 209        
Net loss (16,060) (16,060)
Ending balance, value at Dec. 31, 2023 $ 14 142,265 (93,361) 624 49,542
Ending balance, shares at Dec. 31, 2023 14,398        
Stock issued for director services - vested 462 463
Stock issued for director services - vested, shares 72        
Stock issued to (released from) escrow account - unvested
Stock issued to (released from) escrow account - unvested, shares 82        
Stock-based compensation to consultants 278 278
Stock-based compensation to consultants, shares 62        
Employee stock-based compensation expense 2,538 2,538
Proceeds from issuance of common stock, pursuant to public offering 1 1
Warrants exercised for cash 810 810
Warrants exercised for cash, shares 128        
Stock option exercise and restricted stock unit vestings (cashless) (164) (164)
Stock option exercise and restricted stock unit vestings (cashless), shares 12        
Impact of foreign currency translation (1,780) (1,781)
Stock issued for acquisition and expenses 387 387
Sale of stock under Committed Equity Facility 496 496
Sale of stock under Committed Equity Facility, shares 82        
Net loss (11,282) (11,282)
Ending balance, value at Dec. 31, 2024 $ 15 $ 147,072 $ (104,643) $ (1,156) $ 41,288
Ending balance, shares at Dec. 31, 2024 14,919